Wednesday, May 14, 2025 10:29:36 AM
"I think its clear we received an additional RFI. the request may have been due to a poor submission."
pure speculation.
I was critical of bonuses and a few other things I personally didn't like, such as the being caught by surprise in the May TLD announcement attack and the silence thereafter.
I can't criticize what they are going to do after approval because it hasnt happened yet. I have been against pumping as well as FUD misrepresentations. I am trying to believe in the "if you didnt hear it from us it didn't happen" statement. I stopped doing backflips over breadcrumbs years ago as SP kept falling. I believe there must be plenty going on behind the scenes, but I will not believe speculation anymore good or bad.
I've just seen too much of "cofer black will get you all, naked short shares are in the billions, shorties gonna burn, good for all cancers, multiple RFI's, endpoints, speeches, delays on announcements, what time will they announce, summer slowdown, quiet period, billions in settlement, etc"
pure speculation.
I was critical of bonuses and a few other things I personally didn't like, such as the being caught by surprise in the May TLD announcement attack and the silence thereafter.
I can't criticize what they are going to do after approval because it hasnt happened yet. I have been against pumping as well as FUD misrepresentations. I am trying to believe in the "if you didnt hear it from us it didn't happen" statement. I stopped doing backflips over breadcrumbs years ago as SP kept falling. I believe there must be plenty going on behind the scenes, but I will not believe speculation anymore good or bad.
I've just seen too much of "cofer black will get you all, naked short shares are in the billions, shorties gonna burn, good for all cancers, multiple RFI's, endpoints, speeches, delays on announcements, what time will they announce, summer slowdown, quiet period, billions in settlement, etc"
Recent NWBO News
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
